Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Amortization - GoodwillEBIATLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsShares IssuedShares OutstandingWages, Salaries and Other
Ratios

Harvard Bioscience (HBIO) Short-Term Debt repayments (2021 - 2024)

Historic Short-Term Debt repayments for Harvard Bioscience (HBIO) over the last 4 years, with Q2 2024 value amounting to $2.0 million.

  • Harvard Bioscience's Short-Term Debt repayments fell 3050.85% to $2.0 million in Q2 2024 from the same period last year, while for Mar 2025 it was $2.0 million, marking a year-over-year decrease of 7709.5%. This contributed to the annual value of $2.6 million for FY2024, which is 7671.23% down from last year.
  • Harvard Bioscience's Short-Term Debt repayments amounted to $2.0 million in Q2 2024, which was down 3050.85% from $500000.0 recorded in Q1 2024.
  • Over the past 5 years, Harvard Bioscience's Short-Term Debt repayments peaked at $4.0 million during Q1 2021, and registered a low of -$1.8 million during Q4 2021.
  • Over the past 4 years, Harvard Bioscience's median Short-Term Debt repayments value was $2.5 million (recorded in 2023), while the average stood at $2.0 million.
  • Per our database at Business Quant, Harvard Bioscience's Short-Term Debt repayments surged by 19722.22% in 2022 and then plummeted by 8000.0% in 2024.
  • Harvard Bioscience's Short-Term Debt repayments (Quarter) stood at -$1.8 million in 2021, then soared by 197.22% to $1.8 million in 2022, then skyrocketed by 42.86% to $2.5 million in 2023, then dropped by 18.0% to $2.0 million in 2024.
  • Its last three reported values are $2.0 million in Q2 2024, $500000.0 for Q1 2024, and $2.5 million during Q4 2023.